Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/ml ursodeoxycholic acid for newborns

Drugs are developed for adults, making it difficult to find suitable treatments for children. Hospital pharmacy has developed alternatives to respond to this medical need. The objective of this study is to present a new liquid formulation of ursodeoxycholic acid (UDCA) at a concentration suitable fo...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology in hospital pharmacy 2020-10, Vol.5 (1), p.36-7
Main Authors: Hausherr, Anne, Roessle, Clara, Pinet, Emma, Vasseur, Véronique, Abarou, Tarik, Benakouche, Samira, Bourdon, Olivier, Storme, Thomas
Format: Article
Language:English
Subjects:
chromatography
clinical pharmacy service
high performance liquid
pediatrics
pharmaceutical preparations
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Drugs are developed for adults, making it difficult to find suitable treatments for children. Hospital pharmacy has developed alternatives to respond to this medical need. The objective of this study is to present a new liquid formulation of ursodeoxycholic acid (UDCA) at a concentration suitable for treatment of neonatal jaundice, and to introduce a novel high pressure liquid chromatography (HPLC) assay method.
ISSN:2365-2411
2365-242X
DOI:10.1515/pthp-2020-0006